Our Speakers
Robert Di Giovanni
Global Patient Safety Lead
Novartis Pharma AG
Jan Petracek
CEO
iVigee
Amina Baljic
Head, PV Operations and PV Excellence
Grünenthal
Dr Merica Kucuku
Consultant & Former Head
National Regulatory Authority of Vaccines & Immunobiological Products, Albania
Dr Avinash Kakde
Vice President & Head of Pharmacovigilance
Cipla
Dr Deepa Arora
Founder & Director
CLINEXEL
Dr Siva Kumar Buddha
bal Phv Surveillance Physician and Senior Manager Medical Scientific Unit
Teva Pharmaceuticals
Uwe Gudat
Chief Medical Officer
Aretaeus sàrl
Mukesh Gori
Director CMO and Patient Safety
Novartis
Mina George
Senior Pharmacovigilance Manager
Kyowa Kirin
Howard Snow
Vice President, Global Head Pharmacovigilance & Development (Clinical) Operations
Luzsana Biotechnology
Dr Vipin Sethi
HOD – Medical Services & Global Pharmacovigilance
Cadila Pharmaceuticals
Dr Kausik Maiti
Senior Medical Director
Parexel International
Vojtech Kvita
CVO
NextPV Services
Be at the World's Leading Pharmacovigilance Summit!
Pharmacovigilance and Drug Safety have garnered an increasing amount of attention. Rising drug demand has raised the need for the development of novel therapeutics through extensive clinical trials, putting immense pressure on R&D companies. These comprehensive clinical drugs must have solid Pharmacovigilance & Risk Management Plans & Programs in place to ensure they have effective, strategically focused PV capability so they can be less reactionary, resource-intensive, and transaction-focused, and instead become a strategic partner.
This year, Equip Global will host the 11th Pharmacovigilance Asia Summit from the 6-9 February 2023 LIVE ONLINE DIGITALLY, with the goal of providing a platform for Continuous Learning and Networking Opportunities. To discuss Case Studies and explore existing and developing strategies and techniques for planning and optimising pharmacovigilance, risk management planning, and signal management activities for known and prospective safety risks of a new product in order to make the best pharmacovigilance decisions.
Join us at this 4-day highly anticipated summit series as we gather Regulatory Authorities, Ministries of Health, Pharmacovigilance & Drug Safety Leaders from across Pharmaceutical & Biotechnology Companies to discuss the new updates in Pharmacovigilance Regulatory Framework & Compliance; AI, Automation and the Future Outlook of Pharmacovigilance; PV Database Management, The use of Analytics & Big Data in Pharmacovigilance; Benefit-Risk Assessment, Risk Management Planning Strategies, The Adoption ofPatient-CentricApproaches in Pharmacovigilance; PV Inspections and Audits Strategies; Effective Detection, Assessment, and Reporting of Adverse Drug Events as well as Signal Detection and Post Marketing Safety & Surveillance.
4 Key Reasons WHY YOU MUST ATTEND THE 11th Pharmacovigilance Asia Summit
CREDIBLE PRESENTATIONS & CASE STUDIES
- Don’t miss out on the opportunity to hear from world-renowned Pharmacovigilance leaders in and across Pharmaceuticals, Biotechnology, Biologics Companies, Medical Devices Organizations CROs, and PV Service Providers on hot-button issues including adverse drug event reporting lessons learned, balancing efficacy with safety during clinical trials, validating large amounts of electronic health data and their authenticity and harmonization in pharmacovigilance.
FOCUSED PANEL DISCUSSIONS & INTERACTIVE Q&A Sessions
- Be sure to take part in insightful sessions with high participant involvement to get your burning questions ANSWERED across the biggest challenges in pharmacovigilance including risk management planning, adverse drug reaction reporting and PV data integration & analysis!
IN-DEPTH EXPERT-LED WORKSHOPS
- Register for these specially crafted pharmacovigilance workshops designed to equip and strengthen your team's capabilities and knowledge in AI/ML/Automation, Data Analytics in Pharmacovigilance, PV inspections & audits, Signal Management, as well as Pharmacovigilance Risk Management Planning & Minimization Measures.
BRIDGING THE GAP
- Leverage on this unique industry platform to network and learn from Global & Regional Regulatory Bodies, Healthcare Industry Professionals, Physicians, Pharma/Biotech Companies, CROs in order to elevate your pharmacovigilance knowledge to a whole new level!
WHO SHOULD ATTEND
Industry leaders seeking to broaden their network of like-minded professionals and gain practical knowledge in crucial aspects of pharmacovigilance, including:
Vice Presidents, Directors, Heads & Managers, Scientific Advisors, Heads, Managers, Scientists and Professionals of the following departments
● Pharmacovigilance
● Drug Safety
● Drug Monitoring
● Risk Management Planning
● Risk management, including Risk Evaluation and Mitigation Strategies (REMS)
● Benefit-risk assessment and communication
● Medical product safety assessment
● Post-market studies and Real-world evidence generation
● PV Compliance
● Regulatory affairs
● Clinical research
● Data safety monitoring and analysis
● Pharmacoepidemiology
● Medical information, Medical Communications, Medical Affairs
● Inspection & Audit
● Health outcomes
● Customer Engagement Programs, including Patient Support Programs
● QPPV
● Scientific Affairs
Like More information?
Email us at enquiry@equip-global.com for more information!